Clinical Trials Logo

Clinical Trial Summary

This randomized controlled experimental study was conducted prospectively with 80 patients with hematological malignancies were treated in the adult bone marrow transplant unit and adult hematology service of a private hospital between May 2021 and January 2022. Orange oil inhalation used in aromatherapy was applied to patients in the intervention group. Visual Analogue Scale and the State-Trait Anxiety Inventory used for data collection.


Clinical Trial Description

Introduction: Invasive interventions such as peripheral intravenous cannula and port needle placement, and blood collection are often required for both inpatient and outpatient follow-up patients with hematological malignancies and hematopoietic stem cell transplantation patients. This long and difficult treatment process causes anxiety and emotional disorders in most patients. Although invasive initiatives in the treatment and monitoring process are widely implemented, they lead to pain, anxiety and discomfort, which is often ignored. This study conducted to assess the effect of orange oil inhalation used in aromatherapy on pain and anxiety levels in invasive interventions to treat patients with hematological malignancies and hematopoietic stem cells transplantation. Methods: This randomized controlled experimental study was conducted prospectively with 80 patients with hematological malignancies were treated in the adult bone marrow transplant unit and adult hematology service of a private hospital between May 2021 and January 2022. Orange oil inhalation used in aromatherapy was applied to patients in the intervention group. Visual Analogue Scale and the State-Trait Anxiety Inventory used for data collection. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05391347
Study type Interventional
Source Istanbul Aydin University
Contact
Status Completed
Phase N/A
Start date May 1, 2021
Completion date January 30, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT06148610 - Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients' Quality of Life and Support
Completed NCT02212236 - Psychological Intervention for Distress During HSCT Phase 2
Completed NCT00023530 - Blood and Marrow Transplant Clinical Research Network N/A
Completed NCT01466335 - An Adaptive Phase I Study to Evaluate the Safety, Efficacy and Dose Responses of Ronacaleret in Healthy Human Volunteers Phase 1
Withdrawn NCT02682953 - Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers Phase 2
Completed NCT00775632 - Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants Phase 2
Completed NCT00048256 - Relationship Between Personality and Coping Styles in Bone Marrow Transplant Candidates N/A
Completed NCT00004994 - Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive Chemotherapy and Radiation Preceding a Bone Marrow Transplant N/A
Completed NCT04039100 - Family Caregiver Ambassador Support for Family Caregivers of Patients With Hematological Disease N/A
Completed NCT04535570 - Evolution of the Energy Expenditure During Hematopoietic Stem Cell Transplantation
Recruiting NCT06118853 - Impact of Yoga and Gentle Massage Practices on Symptom Management in Patients Undergoing HSCT N/A
Active, not recruiting NCT01016093 - Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major Patients Phase 2/Phase 3
Completed NCT01015183 - Prevention Chemotherapy Induced Mucositis by Zinc Sulfate Phase 2/Phase 3
Completed NCT00843180 - Massage for Pediatric Oncology N/A
Completed NCT00000591 - T-Cell Depletion in Unrelated Donor Marrow Transplantation Phase 3
Completed NCT04474730 - Physical Activity Monitoring Among BMT Patients N/A
Completed NCT02733744 - Fecal Microbiota Transplantation After HSCT Early Phase 1
Active, not recruiting NCT02319226 - Toward Immune Biomarkers for Tolerance and GvHD in Humans
Recruiting NCT00673348 - Therapeutic Drug Monitoring (TDM) of Voriconazole and Correlation With CYP2C19 Genotype in Korean Populations N/A
Completed NCT00005556 - Retention of Bone Marrow Donors in a National Registry N/A